Kandimalla's group has reported a risk-score derived from a seven gene mRNA expression classifier consisting of METTL3, METTL14, WTAP, YTHDF1, YTHDF2, FTO, and ALKBH5 that associated with poor disease-free survival of CRC patients (29). The gene discussed is METTL14; the disease is colorectal carcinoma.